A safety study on intrathecal delivery of autologous mesenchymal stromal cells in rabbits directly supporting Phase I human trials

Transfusion

Volumn 55, Issue 5, 2015, Pages 1013-1020

  Chen, Bingkun K ^a   Staff, Nathan P ^a   Knight, Andrew M ^a   Nesbitt, Jarred J ^a   Butler, Greg W ^a   Padley, Douglas J ^a   Parisi, Joseph E ^a   Dietz, Allan B ^a   Windebank, Anthony J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS MESENCHYMAL STROMA CELL; AUTOTRANSPLANTATION; BLOOD CELL COUNT; BODY WEIGHT; CELL ISOLATION; CEREBROSPINAL FLUID; CONTROLLED STUDY; FORAMEN MAGNUM; FUNCTIONAL ASSESSMENT; HISTOPATHOLOGY; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; RABBIT; RAT; STEM CELL EXPANSION; TUMOR GROWTH; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; BLOOD; CELL CULTURE; DISEASE MODEL; FEMALE; HUMAN; INTRASPINAL DRUG ADMINISTRATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MULTIPLE SYSTEM ATROPHY; ORGAN SIZE; PHASE 1 CLINICAL TRIAL (TOPIC); PHYSIOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELLS, CULTURED; CLINICAL TRIALS, PHASE I AS TOPIC; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INJECTIONS, SPINAL; INTERLEUKIN-6; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MULTIPLE SYSTEM ATROPHY; ORGAN SIZE; RABBITS;

EID: 84929179934     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12938     Document Type: Article

References (50)

1. Rafei M, Campeau PM, Aguilar-Mahecha A, et al. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. J Immunol 2009;182:5994-6002.
2. Prigione I, Benvenuto F, Bocca P, et al. Reciprocal interactions between human mesenchymal stem cells and gamma delta T cells or invariant natural killer T cells. Stem Cells 2009;27:693-702.
3. Bai L, Lennon DP, Eaton V, et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009;57:1192-1203.
4. Vercelli A, Mereuta OM, Garbossa D, et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2008;31:395-405.
5. Stemberger S, Jamnig A, Stefanova N, et al. Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection. PLoS ONE 2011;6:e19808.
6. Zappia E, Casazza S, Pedemonte E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005;106:1755-1761.
7. Gerdoni E, Gallo B, Casazza S, et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 2007;61:219-227.
8. Park HJ, Lee PH, Bang OY, et al. Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease. J Neurochem 2008;107:141-151.
9. Li Y, Chen J, Chen XG, et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002;59:514-523.
10. Matsushita T, Kibayashi T, Katayama T, et al. Mesenchymal stem cells transmigrate across brain microvascular endothelial cell monolayers through transiently formed inter-endothelial gaps. Neurosci Lett 2011;502:41-45.
11. Liu L, Eckert MA, Riazifar H, et al. From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier? Stem Cells Int 2013;2013:435093.
12. Ono K, Yoshihara K, Suzuki H, et al. Preservation of hematopoietic properties in transplanted bone marrow cells in the brain. J Neurosci Res 2003;72:503-507.
13. Hofstetter CP, Schwarz EJ, Hess D, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 2002;99:2199-2204.
14. Deng YB, Liu XG, Liu ZG, et al. Implantation of BM mesenchymal stem cells into injured spinal cord elicits de novo neurogenesis and functional recovery: evidence from a study in rhesus monkeys. Cytotherapy 2006;8:210-214.
15. Ohta M, Suzuki Y, Noda T, et al. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol 2004;187:266-278.
16. Nishida K, Tanaka N, Nakanishi K, et al. Magnetic targeting of bone marrow stromal cells into spinal cord: through cerebrospinal fluid. Neuroreport 2006;17:1269-1272.
17. Satake K, Lou J, Lenke LG,. Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue. Spine 2004;29:1971-1979.
18. Karussis D, Karageorgiou C, Vaknin-Dembinsky A, et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 2010;67:1187-1194.
19. Lee PH, Lee JE, Kim HS, et al. A randomized trial of mesenchymal stem cells in multiple system atrophy. Ann Neurol 2012;72:32-40.
20. Mazzini L, Ferrero I, Luparello V, et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a Phase I clinical trial. Exp Neurol 2010;223:229-237.
21. Glass JD, Boulis NM, Johe K, et al. Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients. Stem Cells 2012;30:1144-1151.
22. Minguell JJ, Pereira A, Bartholomew P, et al. The intrathecal infusion of mesenchymal stem cells into healthy rabbits is safe and devoid of neurological or clinical complications. J Stem Cell Res Ther 2011;2:1-5.
23. Santhanam AV, Smith LA, Katusic ZS,. Brain-derived neurotrophic factor stimulates production of prostacyclin in cerebral arteries. Stroke 2010;41:350-356.
24. Mazzetti MP, Oliveira IS, Miranda-Ferreira R, et al. Qualitative and quantitative analysis of rabbit's fat mesenchymal stem cells. Acta Cir Bras 2010;25:24-27.
25. Santhanam AV, Smith LA, He T, et al. Endothelial progenitor cells stimulate cerebrovascular production of prostacyclin by paracrine activation of cyclooxygenase-2. Circ Res 2007;100:1379-1388.
26. Mamatha SS, Muthukumar SP, Venkateswaran G,. Safety evaluation of Mucor rouxii CFR-G15 biomass containing omega-6 fatty acids in rats. Regul Toxicol Pharmacol 2012;62:183-190.
27. Aguilar S, Nye E, Chan J, et al. Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung. Stem Cells 2007;25:1586-1594.
28. Zimmerlin L, Donnenberg AD, Rubin JP, et al. Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A 2011;17:93-106.
29. Tolar J, Nauta AJ, Osborn MJ, et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007;25:371-379.
30. Tasso R, Augello A, Carida M, et al. Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds. Carcinogenesis 2009;30:150-157.
31. Osaka M, Honmou O, Murakami T, et al. Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res 2010;1343:226-235.
32. Osanai T, Kuroda S, Sugiyama T, et al. Therapeutic effects of intra-arterial delivery of bone marrow stromal cells in traumatic brain injury of rats-in vivo cell tracking study by near-infrared fluorescence imaging. Neurosurgery 2012;70:435-444; discussion 444.
33. Kishk NA, Gabr H, Hamdy S, et al. Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury. Neurorehabil Neural Repair 2010;24:702-708.
34. Shi E, Kazui T, Jiang X, et al. Intrathecal injection of bone marrow stromal cells attenuates neurologic injury after spinal cord ischemia. Ann Thorac Surg 2006;81:2227-2233; discussion 2233-4.
35. Omori Y, Honmou O, Harada K, et al. Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats. Brain Res 2008;1236:30-38.
36. Harris VK, Yan QJ, Vyshkina T, et al. Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis. J Neurol Sci 2012;313:167-177.
37. Zhang C, Zhou C, Teng JJ, et al. Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis. Cytotherapy 2009;11:299-306.
38. Hass R, Kasper C, Bohm S, et al. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 2011;9:12.
39. Griffin MD, Ritter T, Mahon BP,. Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum Gene Ther 2010;21:1641-1655.
40. English K, Mahon BP,. Allogeneic mesenchymal stem cells: agents of immune modulation. J Cell Biochem 2011;112:1963-1968.
41. Bunnell BA, Betancourt AM, Sullivan DE,. New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell Res Ther 2010;1:34.
42. Bifari F, Pacelli L, Krampera M,. Immunological properties of embryonic and adult stem cells. World J Stem Cells 2010;2:50-60.
43. Togel F, Weiss K, Yang Y, et al. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 2007;292:F1626-1635.
44. Ra JC, Shin IS, Kim SH, et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev 2011;20:1297-1308.
45. Crisostomo PR, Wang Y, Markel TA, et al. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B-but not JNK-dependent mechanism. Am J Physiol Cell Physiol 2008;294:C675-682.
46. Kim YJ, Park HJ, Lee G, et al. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia 2009;57:13-23.
47. Joyce N, Annett G, Wirthlin L, et al. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 2010;5:933-946.
48. Trounson A, Thakar RG, Lomax G, et al. Clinical trials for stem cell therapies. BMC Med 2011;9:52.
49. Morita E, Watanabe Y, Ishimoto M, et al. A novel cell transplantation protocol and its application to an ALS mouse model. Exp Neurol 2008;213:431-438.
50. Kim H, Kim HY, Choi MR, et al. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci Lett 2010;468:190-194.